Author

Harshvinder Bhullar

Observed name: H. Bhullar

Institution: IQVIA (United Kingdom)

Observed institutions: IQVIA (United Kingdom), IQVIA (United States)

OpenAlex ID: A5083120046

An Evaluation of the THIN Database in the OMOP Common Data Model for Active Drug Safety Surveillance

2013 · Xiaofeng Zhou, Sundaresan Murugesan, et al. · Drug Safety · 78

Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility

2020 · Donna R. Rivera, Mugdha N. Gokhale, et al. · Pharmacoepidemiology and Drug Safety · 37

Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

2012 · Vincent Lo Re, Kevin Haynes, et al. · Pharmacoepidemiology and Drug Safety · 23

Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)

2015 · Dean M. Carbonari, M. Elle Saine, et al. · Pharmacoepidemiology and Drug Safety · 22

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes

2017 · Vincent Lo Re, Dean M Carbonari, et al. · BMJ Open Diabetes Research & Care · 21

IQVIA Medical Research Data (IMRD)

2021 · Melissa Myland, Caroline O’Leary, et al. · Springer series on epidemiology and public health · 13

Electronic Health Record Databases

2019 · Daniel B. Horton, Harshvinder Bhullar, et al. · Pharmacoepidemiology · 11

Evaluation of methods to estimate missing days’ supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)

2016 · Kirsten J. Lum, Craig W. Newcomb, et al. · European Journal of Clinical Pharmacology · 10

Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti‐diabetic drugs

2017 · M. Elle Saine, Mona Gizaw, et al. · Pharmacoepidemiology and Drug Safety · 9

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

2015 · M Elle Saine, Dean M Carbonari, et al. · BMC Pharmacology and Toxicology · 7

Electronic Health Record Databases

2021 · Daniel B. Horton, Harshvinder Bhullar, et al.

PRM27 A Method of Projecting Future Co-Morbidity Prevalence and Health Service Demand in the United Kingdom Population Using the Health Improvement Network (THIN)

2012 · D.A. Smith, Z. Butt, et al. · Value in Health

Works count: 12

Citation count: 231

H-index: 9

I10-index: 8